Guardant Health has announced that its Guardant Reveal test, a blood-based assay for minimal residual disease (MRD) detection, is now…
Browsing: Hot headlines in GI
The 2025 JP Morgan Healthcare Conference highlighted key trends shaping the biopharma landscape, including a resurgence in dealmaking driven by…
A joint report from the Federal Trade Commission (FTC), Department of Justice (DOJ), and Department of Health and Human Services…
Healthcare spending in the U.S. surged to $4.9 trillion in 2023, marking a 7.5% increase from the previous year, driven…
Castle Biosciences has achieved a significant milestone with New York State Department of Health approval for its TissueCypher® Barrett’s Esophagus…
Gastro Health & Nutrition aims to provide people with the treatment they need to achieve optimal gut health. The gastroenterology…
The FDA has reaffirmed its decision that the shortage of tirzepatide—marketed as Mounjaro (diabetes) and Zepbound (weight loss)—is officially over.…
Colorectal cancer is the second-leading cause of cancer deaths, with rates rising among younger adults. Early detection can prevent cancer…
President Joe Biden signed a short-term spending bill, avoiding a government shutdown but delaying long-term decisions on key healthcare policies.…
Gastroenterology is witnessing a wave of strategic partnerships in 2024, reshaping care delivery, technology integration, and data-driven advancements. From AI-assisted…